Merck adds Lilly neuroscience veteran
Executive Summary
Lilly's global head of neuroscience research and early clinical investigation Darryle Schoepp jumps to Merck where he will serve as senior VP and franchise head of neuroscience, the company says March 5. In that role he will oversee drug discovery and development and report to Merck Research Laboratories President Peter Kim. The most advanced neuroscience product in Merck's pipeline is the Phase III insomnia agent gaboxadol...